The recent ruling by the Delhi High Court regarding Biotyx Medical (Shenzhen) Co. Ltd.’s patent application has significant ...
(Nasdaq: FBLG) (“FibroBiologics , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases ...
Cambridge company coding human cells for novel cures and a pioneer in synthetic biology, has successful defended its ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics, a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development ...
bit.bio, the company coding human cells for novel cures and a pioneer in synthetic biology, today announces the successful defence of its foundational European patent for opti-ox, a breakthrough ...
Services include filing patents, trademarks, and designs. Additionally, the IPFC offers thorough IP searches, prior art ...
The Central Intellectual Property and International Trade Court has confirmed that a design’s overall appearance should be ...
India - Key Considerations For Patenting Nutraceuticals/Dietary Supplements. Legal News and Analysis - India - Intellectual ...
The Madras High Court set aside the rejection of Kymab Limited's patent application, ruling that the invention for antibody ...